Search Results
Aug 27, 2026, 09:00 ET Dolby Laboratories Announces Leadership Transition
SAN FRANCISCO, Aug. 27, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), today announced a new chapter in its leadership as Kevin Yeaman retires from Dolby after nearly two decades with the company and Marc Whitten is appointed
More news about: Dolby Laboratories, Inc.
Aug 13, 2026, 09:00 ET Seattle Seahawks Become First Team to Bring Dolby OptiView with Dolby Vision to Fans
Dolby Laboratories (NYSE: DLB) and the world champion Seattle Seahawks announced an integrated partnership bringing Dolby's industry-leading streaming and video technology to Seahawks
More news about: Dolby Laboratories, Inc.
Aug 06, 2026, 09:00 ET Dolby Vision 2 Arrives, Bringing Dolby's Most Advanced Picture Experience Yet to Hisense TVs
Dolby Laboratories (NYSE: DLB) and Hisense announced that Dolby Vision 2 is now available on select Hisense televisions with more models to receive firmware updates in the coming
More news about: Dolby Laboratories, Inc.
Jul 30, 2026, 16:15 ET Dolby Laboratories Reports Third Quarter 2026 Financial Results
forward-looking statements whether as a result of new information, future events, or otherwise.About Dolby Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Dolby Laboratories, Inc.
Jul 14, 2026, 16:15 ET Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2026 Financial Results
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the third quarter (Q3) fiscal year 2026 after the close of regular
More news about: Dolby Laboratories, Inc.
Jun 30, 2026, 02:53 ET New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
α-synuclein pathology will be discussed, primarily across Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB).Key oral lecanemab presentations at AAICSubcutaneous treatment data: On Sunday, July 12, as part
More news about: BioArctic
Jun 30, 2026, 02:44 ET New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
α-synuclein pathology will be discussed, primarily across Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB).Key oral lecanemab presentations at AAICSubcutaneous treatment data: On Sunday, July 12, as part
More news about: BioArctic
Jun 05, 2026, 10:00 ET Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First
Dolby Laboratories (NYSE: DLB) and NBCUniversal announced that Peacock will stream Telemundo's live FIFA World Cup 2026™ Spanish-language coverage in Dolby Vision and Dolby Atmos
More news about: Dolby Laboratories, Inc.
May 29, 2026, 08:30 ET Dolby and rednote Bring More Immersive Storytelling to Video Content with Dolby Atmos
Dolby Laboratories (NYSE: DLB) , a leader in immersive entertainment, and rednote, the leading lifestyle interest community, today announced the launch of Dolby Atmos content sharing
More news about: Dolby Laboratories, Inc.
May 27, 2026, 08:08 ET SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies
aggregation of α-synuclein (α-syn). Representative diseases include Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). In early clinical stages, these diseases often present overlapping symptoms, including bradykinesia, tremor, gait instability, balance impairment,
More news about: SynuSight Biotech
May 20, 2026, 09:00 ET Dolby Recognized as 2025 Supplier of the Year and Overdrive Award Winner by General Motors
(NYSE: DLB), a leader in immersive entertainment, has earned two of the automotive industry's most prestigious supplier honors from General Motors: the 2025 Supplier
More news about: Dolby Laboratories, Inc.
May 19, 2026, 16:15 ET Dolby Laboratories to Present at Upcoming Investor Conferences
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Dolby Laboratories, Inc.
May 07, 2026, 09:43 ET WARNER BROS. DISCOVERY TIPS OFF THE 30TH ANNIVERSARY OF SPACE JAM
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Warner Bros. Discovery
Apr 30, 2026, 16:15 ET Dolby Laboratories Reports Second Quarter 2026 Financial Results
SAN FRANCISCO, April 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) today announced the company's financial results for the second quarter of fiscal 2026.
More news about: Dolby Laboratories, Inc.
Apr 22, 2026, 10:00 ET Dolby and BMW Bring Dolby Atmos to the BMW 7 Series, Expanding Immersive Audio Across Future Models
Dolby Laboratories (NYSE: DLB) and BMW today announced the debut of Dolby Atmos in the new BMW 7 Series, bringing immersive audio into the vehicle cabin and marking the start of its
More news about: Dolby Laboratories, Inc.
Apr 15, 2026, 16:30 ET EVO Entertainment to Bring Dolby Vision+Atmos Across Its EVX Auditoriums
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Dolby Laboratories, Inc.
Apr 09, 2026, 07:30 ET Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
disease-modifying therapies available for treatment of PD or related synucleinopathies such as multiple systems atrophy (MSA) and dementia with Lewy bodies (DLB). These diseases are each characterized by presence of Lewy bodies enriched in αSyn protein and are thus collectively known as synucleinopathies. Recent
More news about: Galmed Pharmaceuticals Ltd.
Apr 08, 2026, 16:15 ET Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2026 Financial Results
SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2026 after the close of regular
More news about: Dolby Laboratories, Inc.
Mar 24, 2026, 07:00 ET Dolby Named to Fast Company's Annual List of the World's Most Innovative Companies List for Fourth Time
Dolby Laboratories, Inc. (NYSE: DLB) is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2026. This year's list shines a spotlight
More news about: Dolby Laboratories, Inc.
Feb 03, 2026, 03:10 ET Source-Connect 4 Becomes First metadata-connected Dolby® Atmos remote review & approval tool
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Source Elements
Jan 29, 2026, 16:15 ET Dolby Laboratories Reports First Quarter 2026 Financial Results
forward-looking statements whether as a result of new information, future events, or otherwise.About Dolby Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Dolby Laboratories, Inc.
Jan 13, 2026, 16:15 ET Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results
SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal year 2026 after the close of regular
More news about: Dolby Laboratories, Inc.
Jan 06, 2026, 08:30 ET Dolby Sets the New Standard for Premium Entertainment at CES 2026
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound
More news about: Dolby Laboratories, Inc.
Jan 05, 2026, 21:30 ET NBCUniversal's Peacock to Be First Streamer to Integrate Dolby's Full Suite of Premium Picture and Sound Innovations
DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and
More news about: Dolby Laboratories, Inc.
Dec 18, 2025, 08:30 ET The Movie Experience SLO Becomes First U.S. Exhibitor to Adopt Dolby Vision+Atmos Theatrical Solution
SAN FRANCISCO and SAN LUIS OBISPO, Calif., Dec. 18, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, today announced that The Movie Experience SLO: Downtown Centre Cinemas, the oldest existing theatre
More news about: Dolby Laboratories, Inc.